7,551.95

+175.09

+2.37%

52,385.47

+1,099.74

+2.14%

25,243.46

+664.03

+2.70%

2,829.79

+75.69

+2.75%

4.8840

+0.0250

+0.51%

20.36

-5.28

-20.60%

4,113.60

+38.70

+0.95%

74,734.60

-919.27

-1.22%

Crude Oil Dec 26

87.79

-3.04

-3.35%

US Private Equity

10,772.76

+11.83

+0.11%

NasdaqGS - Nasdaq Real Time Price USD

Anavex Life Sciences Corp. (AVXL)

1.2500 +0.1000 (+8.70%)

As of 12:31:12 PM EST. Market Open.

Trade AVXL on Coinbase

Loading Chart for AVXL

Chart Range Bar

Interval:

In partnership with ChartIQ

Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors

Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors

Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies

Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies

Anavex Receives FDA IND Clearance for Blarcamesine in Fragile X Syndrome, Enabling Phase 2a Trial

Anavex Receives FDA IND Clearance for Blarcamesine in Fragile X Syndrome, Enabling Phase 2a Trial

Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome

Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome

Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting

Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting

PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences

PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences

PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance

PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance

PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign

PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign

Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET

Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET

PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company

PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company

PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting

PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting

Mobilize your Website

View Site in Mobile | Classic

Share by: